Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Philips NV
  6. News
  7. Summary
    PHIA   NL0000009538

PHILIPS NV

(PHIA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Philips : Three ways the private sector can help build health system resilience

09/15/2021 | 11:12am EDT

We already know that primary care can strengthen health systems, and, more importantly, improve people's health. According to the World Bank, primary care can manage 90% of healthcare demands.[4] This makes it the most cost-effective way to address comprehensive health needs close to people's homes and communities.[5] In addition, well-designed primary healthcare has the potential to help flatten the curve during a health crisis like COVID-19.[6] There is broad consensus that primary care is foundational to achieving universal health coverage (UHC) and creating a resilient healthcare system. Countries closest to achieving UHC have been the most resilient during the COVID crisis.[7] Therefore, to build resilient and sustainable health systems, we must find ways to unlock investments in primary healthcare.

However, financing is the biggest bottleneck in expanding primary care, especially in emerging countries. Traditional funding models - grants and loans - are inadequate, while commercial loans are too expensive. And only a fraction of social impact investments goes toward funding primary care due to risk aversion of the investors.

The question is how to create financing vehicles that unlock long-term investments in primary healthcare and ensure an acceptable return to the investors. The challenge is that primary healthcare is free in most emerging countries, so how would investments yield returns when patients don't pay anything? Payment systems are generally run by governments who often reimburse at rates that are too low. Narrow returns, high initial costs, and reliance on government support can cause investors to see primary care as too high-risk.

We need to find additional and reliable returns to lower investor risk. If investments have their return from system-sustaining funds - like reimbursement payments or insurance premiums - 'topped up' with alternative revenues, it could make primary care business models more viable and sustainable.

An innovative financing vision called 'double blended' financing, which Philips developed together with Total Impact Capital, could help unlock much needed investments by strengthening both the investment and the revenue side (returns) of investments. A double blended approach involves using investment blending to cushion an investment and reduce early-stage risk, as well as revenue blending to minimize long-term risk and increase cash-flow sustainability. Philips and Total Impact Capital are partnering with the Health Finance Coalition to convert that vision into an initial double blended investment vehicle. The ambition is to make quality primary healthcare affordable and accessible across Africa by making it investable.

Disclaimer

Royal Philips NV published this content on 15 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 September 2021 15:11:13 UTC.


© Publicnow 2021
All news about PHILIPS NV
10/21PHILIPS : brings clarity to every moment of cancer care with new patient-centered innovati..
GL
10/21Royal Philips Announces New Innovations to Help Improve Cancer Care Across Patient Jour..
CI
10/21PHILIPS : Seeing the bigger picture … and taking action together!
PU
10/21PHILIPS : "Al bij de eerste design-schets moet je nadenken over circulariteit"
PU
10/20European ADRs Move Slightly Higher in Wednesday Trading
MT
10/20PHILIPS NV : Jefferies maintains a Buy rating
MD
10/19European ADRs 0.6% Higher Tuesday Morning
MT
10/19PHILIPS NV : Receives a Buy rating from UBS
MD
10/19PHILIPS NV : Deutsche Bank reiterates its Neutral rating
MD
10/19PHILIPS NV : JP Morgan gives a Neutral rating
MD
More news
Analyst Recommendations on PHILIPS NV
More recommendations
Financials
Sales 2021 17 551 M 20 442 M 20 442 M
Net income 2021 3 577 M 4 166 M 4 166 M
Net Debt 2021 4 142 M 4 825 M 4 825 M
P/E ratio 2021 9,34x
Yield 2021 2,20%
Capitalization 37 350 M 43 445 M 43 501 M
EV / Sales 2021 2,36x
EV / Sales 2022 2,21x
Nbr of Employees 77 084
Free-Float 99,4%
Chart PHILIPS NV
Duration : Period :
Philips NV Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PHILIPS NV
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Last Close Price 41,03 €
Average target price 46,60 €
Spread / Average Target 13,6%
EPS Revisions
Managers and Directors
Frans van Houten Chief Executive Officer
Abhijit Bhattacharya Chief Financial Officer & Executive Vice President
Feike Sijbesma Chairman-Supervisory Board
Jan Kimpen Chief Medical Officer
Sophie Bechu Chief Operating Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
PHILIPS NV-6.28%43 445
THERMO FISHER SCIENTIFIC30.02%239 360
DANAHER CORPORATION41.72%221 837
INTUITIVE SURGICAL, INC.25.24%121 328
SIEMENS HEALTHINEERS AG40.64%76 589
EDWARDS LIFESCIENCES CORPORATION26.71%72 144